InsiderTrades.com logo
Will this $2 AI stock double overnight?
From Behind the Markets   |   Ad
It's a tiny AI company fighting for a big piece of a $20 Billion Pentagon contract. What's more, this groundbreaking firm is trading for less than $2 a share!
Click here to learn more >>>
James V. Cassella net worth and biography
  • LinkedIn
  • Phone
  • Email
  • Website

James Cassella Biography and Net Worth

Insider of Concert Pharmaceuticals
Dr. James V. Cassella has served as our Chief Development Officer since February 2015. Prior to joining Concert, Dr. Cassella had senior level roles in biopharmaceutical companies, including Executive Vice President, Research and Development and Chief Scientific Officer of Alexza Pharmaceuticals, Inc. from June 2004 to January 2015. Prior to Alexza Pharmaceuticals, Dr. Cassella held various management positions at Neurogen Corporation, including Senior Vice President, Clinical Research and Development. Before joining the biotechnology industry, Dr. Cassella was Assistant Professor of Neuroscience at Oberlin College. He also serves on the Board of Directors of Trevi Therapeutics, Inc. Dr. Cassella received his Ph.D. in Physiological Psychology from Dartmouth College, completed a postdoctoral fellowship in the Department of Psychiatry at the Yale University School of Medicine and received a B.A. in psychology from the University of New Haven.

What is James V. Cassella's net worth?

The estimated net worth of James V. Cassella is at least $251,100.00 as of April 17th, 2018. Dr. Cassella owns 30,000 shares of Concert Pharmaceuticals stock worth more than $251,100 as of April 24th. This net worth estimate does not reflect any other investments that Dr. Cassella may own. Learn More about James V. Cassella's net worth.

How do I contact James V. Cassella?

The corporate mailing address for Dr. Cassella and other Concert Pharmaceuticals executives is 65 HAYDEN AVENUE SUITE 3000N, LEXINGTON MA, 02421. Concert Pharmaceuticals can also be reached via phone at (781) 860-0045 and via email at [email protected]. Learn More on James V. Cassella's contact information.

Has James V. Cassella been buying or selling shares of Concert Pharmaceuticals?

James V. Cassella has not been actively trading shares of Concert Pharmaceuticals during the last ninety days. Most recently, James V. Cassella sold 8,086 shares of the business's stock in a transaction on Monday, August 16th. The shares were sold at an average price of $3.28, for a transaction totalling $26,522.08. Learn More on James V. Cassella's trading history.

Who are Concert Pharmaceuticals' active insiders?

Concert Pharmaceuticals' insider roster includes Marc Becker (CFO), James Cassella (Insider), Jeffrey Munsie (Insider), Nancy Stuart (COO), and Roger Tung (CEO). Learn More on Concert Pharmaceuticals' active insiders.

James V. Cassella Insider Trading History at Concert Pharmaceuticals

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/16/2021Sell8,086$3.28$26,522.08View SEC Filing Icon  
4/17/2018Sell10,582$20.18$213,544.7630,000View SEC Filing Icon  
See Full Table

James V. Cassella Buying and Selling Activity at Concert Pharmaceuticals

This chart shows James V Cassella's buying and selling at Concert Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Concert Pharmaceuticals Company Overview

Concert Pharmaceuticals logo
Concert Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which discovers and develops novel small molecule drugs through the use of deuterium technology. Its product candidates target a range of diseases including autoimmune disorders, inflammation, and central nervous system disorders. The company was founded by Richard H. Aldrich, Roger D. Tung and Christoph H. Westphal on April 12, 2006 and is headquartered in Lexington, MA.
Read More

Today's Range

Now: $8.37
Low: $8.37
High: $8.37

50 Day Range

MA: $8.37
Low: $8.33
High: $8.40

2 Week Range

Now: $8.37
Low: $2.66
High: $8.55

Volume

N/A

Average Volume

2,970,800 shs

Market Capitalization

$401.26 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.52
Will this $2 AI stock double overnight?
From Behind the Markets   |   Ad
It's a tiny AI company fighting for a big piece of a $20 Billion Pentagon contract. What's more, this groundbreaking firm is trading for less than $2 a share!
Click here to learn more >>>